david graham stepping plate saying fda needs get together actually protect safety public crazy idea eh according reuters fda scientist dr david graham told congressional hearing drugmaker agency knew long time risk weight gain zyprexa could trigger diabetes fda typical dragging feet post marketing safety issues told reuters house representatives energy commerce subcommittee hearing graham review zyprexa said public testimony criticizing fda actions merck co inc mrk quote profile research withdrawn vioxx painkiller agency staffers came concerns graham also said congress investigate fda handling zyprexa regarding safety concerns people fda seem care issues hat tip furious seasons pharmagossip